A method for identifying sensitivity to low-dose ionizing radiation and cancer patient prognosis. Several predictor panels of genes that are predictive for increased or decreased susceptibility for LD-induced cancer and predictor panel that are predictive for increased or decreased disease free survival in women who are newly diagnosed with breast cancer.
STATEMENT OF GOVERNMENTAL SUPPORT
 The invention was made with government support under Contract No. DE-AC02-05CH11231 awarded by the U.S. Department of Energy and Lawrence Berkeley National Lab Directed Research and Development (LDRD) Program funding. The government has certain rights in the invention.